Abstract

Abstract The avermectins are macrocyclic lactones with exceptional potency and spectrum of activity against nematode and arthropod parasites. They are produced by a new species of actinomycete, Streptomyces avermitilis. They are active when given orally or parenterally, at dosages of a fraction of a milligram per kilogram, against many immature and mature nematode and arthropod parasites of sheep, cattle, dogs, horses and swine. The avermectins appear to paralyze nematodes and arthropods by potentiating the presynaptic release of gamma-aminobutyric acid, thereby blocking post-synaptic transmission of nerve impulses. A chemically modified derivative, 22,23-dihydroavermectin B1, known generically as ivermectin, has been selected for development.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.